Statistical Computing

Chair: Craig Mcilloney

Our main remit is to provide a forum for the:

  • Exchange of ideas, practices and theories for using programming statistical analyses and the use of statistical computing software when analysing data within the pharmaceutical industry
  • Promoting the professional credibility of PSI, Statistical Programmers and Statisticians within the pharmaceutical industry
  • Enhancing the understanding, collaboration and interaction of the differing skill sets required by Statisticians and Statistical Programmers

This is achieved by the Committee supporting and collaborating with other groups and committees within PSI to help them meet their objectives and those of the statistical computing PSI community to include the organisation of half/full-day meetings where necessary.

Meetings

Past meetings have covered a wide range of topics including software for graphics, simulation, data warehousing, validation of systems and code, CANDAs (Computer Assisted New Drug Applications), reporting software, PK software and various other statistical packages.

Composition

Craig McIlloney (Chair)

PPD

Jim Ditchburn

PRA

Steve Jones

Covance

Ann Fitzherbert

GSK

Vinod Kaippillil Mukundaprasad

Shire

Vinod Panangattiri Parambil

Roche

Lyndsey Taylor

Sheffield University

Yingbo Wang

Imperial College London

Committee Resources
stats computing remit

Recent Activity


Latest News


Show all news

EventsFuture Events


  • Patient Engagement in Clinical Trials Webinar - Dates: 13 – 13 Jun, 2017

    Following on from the successful and thought-provoking presentation at last year’s PSI conference by Paul Wicks from PatientsLikeMe, this webinar will continue to explore the ways in which patients are influencing the design of new clinical trials.
  • BBS / PSI One-day Event on Cancer Immunotherapy - Dates: 15 Jun, 2017

    This joint Basel Biometric Society / PSI one day meeting will present an overview of the science and potential statistical challenges across a range of topics covering early and late phases of development, regulatory and health technology assessments.
Merck Logo2

Associate Director, Biostatistician

read more...

Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...